Tonix Pharmaceuticals Holding (TNXP) Operating Margin (2023 - 2025)
Historic Operating Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 1005.08%.
- Tonix Pharmaceuticals Holding's Operating Margin fell 4539100.0% to 1005.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 969.97%, marking a year-over-year increase of 2836900.0%. This contributed to the annual value of 1354.28% for FY2024, which is 1696600.0% up from last year.
- Latest data reveals that Tonix Pharmaceuticals Holding reported Operating Margin of 1005.08% as of Q3 2025, which was down 4539100.0% from 1416.22% recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's Operating Margin's 5-year high stood at 551.17% during Q3 2024, with a 5-year trough of 3501.63% in Q2 2024.
- For the 3-year period, Tonix Pharmaceuticals Holding's Operating Margin averaged around 1143.86%, with its median value being 860.23% (2024).
- The largest annual percentage gain for Tonix Pharmaceuticals Holding's Operating Margin in the last 5 years was 20854100bps (2025), contrasted with its biggest fall of -4539100bps (2025).
- Tonix Pharmaceuticals Holding's Operating Margin (Quarter) stood at 723.18% in 2023, then dropped by -20bps to 870.64% in 2024, then fell by -15bps to 1005.08% in 2025.
- Its last three reported values are 1005.08% in Q3 2025, 1416.22% for Q2 2025, and 660.93% during Q1 2025.